子宫移植中的辅助生殖技术策略
本文综述子宫移植中辅助生殖技术的应用策略,讨论卵巢刺激与子宫准备等ART相关实操问题。文章指出绝对性子宫因素不孕目前唯一选择是实验性子宫移植,随着技术成熟,适应证已从先天性或获得性子宫缺失扩大至不可治愈的子宫纤维化或Asherman综合征。
要点
- 绝对性子宫因素不孕目前唯一选择是实验性子宫移植。
- 子宫移植适应证已从先天性或获得性子宫缺失扩大至不可治愈的子宫纤维化或Asherman综合征。
- 综述讨论子宫移植中卵巢刺激与子宫准备等ART相关实操问题。
核心结论
- 绝对性子宫因素不孕目前唯一选择是实验性子宫移植,随着技术逐步掌握,适应证已从先天性或获得性子宫缺失扩大至不可治愈的子宫纤维化或Asherman综合征。
研究设计与样本
- 本文为综述,讨论子宫移植中辅助生殖技术相关的卵巢刺激与子宫准备等实操问题。
主要发现
- 四十年来辅助生殖技术的发展已能为几乎所有形式的不孕提供终极治疗,但绝对性子宫因素不孕仍无法通过ART及其常规变体解决。
- 过去几年子宫移植取得进展,更多工作正在进行以简化流程,尤其是简化子宫供体的子宫切取步骤。
- 随着技术更好地掌握,子宫移植的原始适应证(先天性或获得性子宫缺失)现已扩大至不可治愈的子宫纤维化或Asherman综合征。
临床怎么用
- 作者在综述中讨论子宫移植相关的卵巢刺激与子宫准备等ART实操问题。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The development of assisted reproductive technology (ART) through four decades has led to offer the ultimate treatment for nearly all forms of infertility. The only remaining factor of childlessness however that still eludes ART and its routine variants are the absolute uterine infertility factors, for which the only option is an experimental approach, uterus transplantation. Progresses has been made over the past few years, and more are underway for simplifying the process notably for simplifying the uterus extraction step performed in the uterus donor. Furthermore, as the technique is being better mastered, the original indications for uterus transplantation, the congenital or acquired absence of the uterus, are now widened to also include incurable uterine fibrosis, or Asherman's syndrome. The ART-related practicalities of uterus transplantation, ovarian stimulation and uterine priming are being discussed in the present review.
引用
- de Ziegler D, Pirtea P, Carbonnel M, et al. Assisted reproductive technology strategies in uterus transplantation. Fertil Steril. 2019. PMID: 31277762. doi:10.1016/j.fertnstert.2019.05.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。